Amylin Receptor Signaling in the Nucleus Accumbens Negatively Modulates μ-opioid-Driven Feeding

Antipsychotic-Like Actions of the Satiety Peptide, Amylin, in Ventral Striatal Regions Marked by Overlapping Calcitonin Receptor and RAMP-1 Gene Expression

(2014) S. K. Baisley et al.   JOURNAL OF NEUROSCIENCE

Amylin Receptor Signaling in the Ventral Tegmental Area is Physiologically Relevant for the Control of Food Intake

(2013) Elizabeth G Mietlicki-Baase et al.   NEUROPSYCHOPHARMACOLOGY

Enkephalin Surges in Dorsal Neostriatum as a Signal to Eat

(2012) Alexandra G. DiFeliceantonio et al.   CURRENT BIOLOGY

Pharmacological Interventions for Binge Eating: Lessons from Animal Models, Current Treatments, and Future Directions

(2012) Laura A. Berner et al.   CURRENT PHARMACEUTICAL DESIGN

Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjects

(2012) H Ziauddeen et al.   MOLECULAR PSYCHIATRY

The effect of pramlintide acetate on glycemic control and weight in patients with type 2 diabetes mellitus and in obese patients without diabetes: a systematic review and meta-analysis

(2010) D. Singh-Franco et al.   DIABETES OBESITY & METABOLISM

Activating μ-opioid receptors in the lateral parabrachial nucleus increases c-Fos expression in forebrain areas associated with caloric regulation, reward and cognition

(2009) M. DenBleyker et al.   NEUROSCIENCE

Muscarinic receptor antagonism causes a functional alteration in nucleus accumbens μ-opiate-mediated feeding behavior

(2008) M PERRY et al.   BEHAVIOURAL BRAIN RESEARCH

Receptor Activity-Modifying Proteins Differentially Modulate the G Protein-Coupling Efficiency of Amylin Receptors

(2008) Maria Morfis et al.   ENDOCRINOLOGY